These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17942747)

  • 1. Identification of a novel ligand binding residue Arg38(1.35) in the human gonadotropin-releasing hormone receptor.
    Stewart AJ; Sellar R; Wilson DJ; Millar RP; Lu ZL
    Mol Pharmacol; 2008 Jan; 73(1):75-81. PubMed ID: 17942747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asn102 of the gonadotropin-releasing hormone receptor is a critical determinant of potency for agonists containing C-terminal glycinamide.
    Davidson JS; McArdle CA; Davies P; Elario R; Flanagan CA; Millar RP
    J Biol Chem; 1996 Jun; 271(26):15510-4. PubMed ID: 8663086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations.
    Lu ZL; Gallagher R; Sellar R; Coetsee M; Millar RP
    J Biol Chem; 2005 Aug; 280(33):29796-803. PubMed ID: 15967801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate 301 of the mouse gonadotropin-releasing hormone receptor confers specificity for arginine 8 of mammalian gonadotropin-releasing hormone.
    Flanagan CA; Becker II; Davidson JS; Wakefield IK; Zhou W; Sealfon SC; Millar RP
    J Biol Chem; 1994 Sep; 269(36):22636-41. PubMed ID: 7915716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Tyr(290(6.58)) of the human gonadotropin-releasing hormone (GnRH) receptor as a contact residue for both GnRH I and GnRH II: importance for high-affinity binding and receptor activation.
    Coetsee M; Millar RP; Flanagan CA; Lu ZL
    Biochemistry; 2008 Sep; 47(39):10305-13. PubMed ID: 18771291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimaeric gonadotropin-releasing hormone (GnRH) peptides with improved affinity for the catfish (Clarias gariepinus) GnRH receptor.
    Blomenröhr M; ter Laak T; Kühne R; Beyermann M; Hund E; Bogerd J; Leurs R
    Biochem J; 2002 Feb; 361(Pt 3):515-23. PubMed ID: 11802781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary structure of the third extracellular loop responsible for ligand selectivity of a mammalian gonadotropin-releasing hormone receptor.
    Petry R; Craik D; Haaima G; Fromme B; Klump H; Kiefer W; Palm D; Millar R
    J Med Chem; 2002 Feb; 45(5):1026-34. PubMed ID: 11855982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants for ligand-receptor conformational selection in a peptide G protein-coupled receptor.
    Lu ZL; Coetsee M; White CD; Millar RP
    J Biol Chem; 2007 Jun; 282(24):17921-9. PubMed ID: 17452338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alanine-261 in intracellular loop III of the human gonadotropin-releasing hormone receptor is crucial for G-protein coupling and receptor internalization.
    Myburgh DB; Millar RP; Hapgood JP
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):893-6. PubMed ID: 9560319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of aspartate7.32(302) of the human gonadotropin-releasing hormone receptor in stabilizing a high-affinity ligand conformation.
    Fromme BJ; Katz AA; Roeske RW; Millar RP; Flanagan CA
    Mol Pharmacol; 2001 Dec; 60(6):1280-7. PubMed ID: 11723235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple interactions of the Asp(2.61(98)) side chain of the gonadotropin-releasing hormone receptor contribute differentially to ligand interaction.
    Flanagan CA; Rodic V; Konvicka K; Yuen T; Chi L; Rivier JE; Millar RP; Weinstein H; Sealfon SC
    Biochemistry; 2000 Jul; 39(28):8133-41. PubMed ID: 10889019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the transmembrane domain 4/extracellular loop 2 junction of the human gonadotropin-releasing hormone receptor in ligand binding and receptor conformational selection.
    Forfar R; Lu ZL
    J Biol Chem; 2011 Oct; 286(40):34617-26. PubMed ID: 21832286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular loop 3 (EL3) and EL3-proximal transmembrane helix 7 of the mammalian type I and type II gonadotropin-releasing hormone (GnRH) receptors determine differential ligand selectivity to GnRH-I and GnRH-II.
    Li JH; Choe H; Wang AF; Maiti K; Wang C; Salam A; Chun SY; Lee WK; Kim K; Kwon HB; Seong JY
    Mol Pharmacol; 2005 Apr; 67(4):1099-110. PubMed ID: 15635044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes to gonadotropin-releasing hormone (GnRH) receptor extracellular loops differentially affect GnRH analog binding and activation: evidence for distinct ligand-stabilized receptor conformations.
    Pfleger KD; Pawson AJ; Millar RP
    Endocrinology; 2008 Jun; 149(6):3118-29. PubMed ID: 18356273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residues within transmembrane helices 2 and 5 of the human gonadotropin-releasing hormone receptor contribute to agonist and antagonist binding.
    Hoffmann SH; ter Laak T; Kühne R; Reiländer H; Beckers T
    Mol Endocrinol; 2000 Jul; 14(7):1099-115. PubMed ID: 10894158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of constrained gonadotropin-releasing hormone ligand conformation and receptor selectivity.
    Barran PE; Roeske RW; Pawson AJ; Sellar R; Bowers MT; Morgan K; Lu ZL; Tsuda M; Kusakabe T; Millar RP
    J Biol Chem; 2005 Nov; 280(46):38569-75. PubMed ID: 16157590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH-II analogs for selective activation and inhibition of non-mammalian and type-II mammalian GnRH receptors.
    Maiti K; Li JH; Wang AF; Acharjee S; Kim WP; Im WB; Kwon HB; Seong JY
    Mol Cells; 2003 Oct; 16(2):173-9. PubMed ID: 14651258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction.
    Costa EM; Bedecarrats GY; Mendonca BB; Arnhold IJ; Kaiser UB; Latronico AC
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2680-6. PubMed ID: 11397871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved amino acid residues that are important for ligand binding in the type I gonadotropin-releasing hormone (GnRH) receptor are required for high potency of GnRH II at the type II GnRH receptor.
    Mamputha S; Lu ZL; Roeske RW; Millar RP; Katz AA; Flanagan CA
    Mol Endocrinol; 2007 Jan; 21(1):281-92. PubMed ID: 16973761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of gonadotropin-releasing hormone receptors by protein kinase C: inside out signalling and evidence for multiple active conformations.
    Caunt CJ; Hislop JN; Kelly E; Matharu AL; Green LD; Sedgley KR; Finch AR; McArdle CA
    Endocrinology; 2004 Aug; 145(8):3594-602. PubMed ID: 15059960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.